O
Oramed Pharmaceuticals Inc.
Profile managed by Bizz IdOramed
Israel
11-50 employees
2006
Description
Israeli pharmaceutical company founded in 2006, listed on NASDAQ and TASE. Developing world's first oral insulin (ORMD-0801) for type 2 diabetes, currently in Phase 3. Founded by Miriam Kidron (Hadassah) and her son Nadav Kidron (CEO). Approved in China.